Goldhaber SZ - Search Results

1

Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.

Angchaisuksiri P, Goto S, Farjat AE, Fryk H, Bang SM, Chiang CE, Jing ZC, Kondo K, Sathar J, Tse E, Phusanti S, Kayani G, Weitz JI, Ageno W, Goldhaber SZ, Kakkar AK. Angchaisuksiri P, et al. Among authors: goldhaber sz. Thromb Res. 2021 May;201:63-72. doi: 10.1016/j.thromres.2021.02.024. Epub 2021 Feb 24. Thromb Res. 2021. PMID: 33652328

2

Clinical overview of venous thromboembolism.

Goldhaber SZ. Goldhaber SZ. Vasc Med. 1998;3(1):35-40. doi: 10.1177/1358836X9800300108. Vasc Med. 1998. PMID: 9666530 Review.

3

Laboratory thrombophilias and venous thromboembolism.

Joffe HV, Goldhaber SZ. Joffe HV, et al. Among authors: goldhaber sz. Vasc Med. 2002 May;7(2):93-102. doi: 10.1191/1358863x02vm426ra. Vasc Med. 2002. PMID: 12402989 Review.

4

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.

Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Kucher N, et al. Among authors: goldhaber sz. Arch Intern Med. 2005 Feb 14;165(3):341-5. doi: 10.1001/archinte.165.3.341. Arch Intern Med. 2005. PMID: 15710801

5

Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients.

Kucher N, Tapson VF, Goldhaber SZ; DVT FREE Steering Committee. Kucher N, et al. Among authors: goldhaber sz. Thromb Haemost. 2005 Mar;93(3):494-8. doi: 10.1160/TH04-09-0587. Thromb Haemost. 2005. PMID: 15735800

6

Few predictors of massive deep vein thrombosis.

Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Joffe HV, et al. Among authors: goldhaber sz. Thromb Haemost. 2005 Nov;94(5):986-90. doi: 10.1160/TH05-05-0314. Thromb Haemost. 2005. PMID: 16363241

7

Venous thromboembolism in children.

Parasuraman S, Goldhaber SZ. Parasuraman S, et al. Among authors: goldhaber sz. Circulation. 2006 Jan 17;113(2):e12-6. doi: 10.1161/CIRCULATIONAHA.105.583773. Circulation. 2006. PMID: 16418440 Review. No abstract available.

8

Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategy.

Goldhaber SZ. Goldhaber SZ. J Thromb Thrombolysis. 2006 Feb;21(1):51-2. doi: 10.1007/s11239-006-5576-7. J Thromb Thrombolysis. 2006. PMID: 16475042

9

D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.

Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M. Shrivastava S, et al. Among authors: goldhaber sz. J Thromb Haemost. 2006 Jun;4(6):1208-14. doi: 10.1111/j.1538-7836.2006.01935.x. J Thromb Haemost. 2006. PMID: 16706961 Free article. Clinical Trial.

10

Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial.

Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, Shrivastava S, Ridker PM. Cushman M, et al. Among authors: goldhaber sz. J Thromb Haemost. 2006 Oct;4(10):2199-203. doi: 10.1111/j.1538-7836.2006.02140.x. Epub 2006 Jul 26. J Thromb Haemost. 2006. PMID: 16869933 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters